中文版 | English
G2TT
来源类型Book
规范类型其他
Competition in the Pharmaceutical Industry: The Declining Profitability of Drug Innovation
Meir Statman
发表日期1983
出版者AEI Press
出版年1983
语种英语
摘要In the early part of the period 1954–1978, the rate of return on drugs was nearly double the cost of capital, but at the end of the period the return declined to the cost of capital or below. The author traces the causes of this decline in the profitability of drug innovation. The high early profitability attracted new firms, encouraged existing firms to increase their investment in pharmaceutical R&D, introduced many new significant drugs, and produced a more crowded drug market. Advances in pharmacological testing procedures and the effects of drug regulation increased the costs of R&D for a new drug. The declining effective patent period and the increasing competition from generic drugs further threaten the profitability of drug innovation. In view of this, the author maintains, it is crucial that the goal of increasing drug price competition be balanced against the potentially harmful effect on the rate of drug innovation. Meir Statman is assistant professor of finance in the School of Business, University of Santa Clara. Read the full PDF.
主题Economics ; Health Care
标签AEI Press ; drug industry ; Drug policy ; Pharmaceuticals ; R&D
URLhttps://www.aei.org/research-products/book/competition-in-the-pharmaceutical-industry-the-declining-profitability-of-drug-innovation/
来源智库American Enterprise Institute (United States)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/207907
推荐引用方式
GB/T 7714		 Meir Statman. Competition in the Pharmaceutical Industry: The Declining Profitability of Drug Innovation. 1983.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Meir Statman]的文章
百度学术
百度学术中相似的文章
[Meir Statman]的文章
必应学术
必应学术中相似的文章
[Meir Statman]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。